[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

…, A Bridges-Webb, LS Reyes, A Linder, G Sandhar… - Cell, 2021 - cell.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …

[HTML][HTML] T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre …

…, N Gillson, SL Dobson, A Cross, G Sandhar… - The Lancet …, 2022 - thelancet.com
Background Previous infection with SARS-CoV-2 affects the immune response to the first
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …

T-cell and antibody responses to first BNT162b2 vaccine dose in previously SARS-CoV-2-infected and infection-naive UK healthcare workers: a multicentre …

…, D Skelly, N Gillson, SL Dobson, A Cross, G Sandhar… - 2021 - papers.ssrn.com
Background: Following a single dose of BNT162b2 mRNA vaccine, higher antibody titres
are observed following prior SARS-CoV-2 infection than in infection-naive individuals, but T-…

Sustained T cell immunity, protection and boosting using extended dosing intervals of BNT162b2 mRNA vaccine

…, SL Dobson, A Amini, P Supasa, A Cross, G Sandhar… - 2021 - papers.ssrn.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the UK to accelerate population coverage with a single dose. In a study of 503 …

Effects of IQOS on macrophage viability and function

S MALELA, A Scott, D Thickett, G Sandhar - 2019 - Eur Respiratory Soc
Heat not burn (HNB) devices are being sold as a less harmful alternative to traditional
cigarettes. The newest HNB device from Philip Morris, IQOS, produces a smoke free tobacco …

Antibody and T cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naïve health care workers in Sri Lanka

C Jeewandara, A Kamaladasa, PD Pushpakumara… - medRxiv, 2021 - medrxiv.org
Background In order to determine the immunogenicity of a single dose of the AZD1222/Covishield
vaccine in a real-world situation, we assessed the immunogenicity, in a large cohort of …

[HTML][HTML] SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

E Barnes, CS Goodyear, M Willicombe, C Gaskell… - Nature Medicine, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive disease …

[PDF][PDF] What's Inside

HF Flourish - 2006 - womenofoptions.ca
I was a teenage mom who needed to get her life together before she even knew how to.
Finding affordable housing was really important—I could’ve ended up way worse without the …

Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination

MM Painter, D Mathew, RR Goel, SA Apostolidis… - Biorxiv, 2021 - biorxiv.org
The SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions
remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-…

[PDF][PDF] [Evidence summary:] Are people who were previously infected with SARS CoV 2 adequately protected following one dose of a COVID 19 vaccine?[v1. 0]

H Clark, M Morgan, B Leen, P O'Reilly, G Casey… - lenus.ie
The following information resources have been selected by the National Health Library and
Knowledge Service Evidence Virtual Team in response to a question from the National …